Truly a man of patience Pete. The pps will certainly

New Post Public Reply Private Reply Replies (0) Message Board
BooDog petemantx #43289
294
Truly a man of patience Pete. The pps will certainly correct in the right direction once the sparks of the first deal start coming through.
Those "agendas" out there should know their days are numbered.

Wish my crystal ball had that number!

Quote:
Trying to get this restored on IHUB since I don't see how it could possibly be removed as being off topic (no need to guess who most likely removed it - phft). Post was a response to a question posed as to how many real longs are on the IHUB board and view the posts:

I have the naysayers on ignore. Amazing how few posts are really made by those that I believe actually have skin in the game. I differentiate between the two by those that actually provide some sort of DD or cognitive input, do not post repetitiously day after day the same dogma of data and events years old, that aren't posters with many aliases, and don't show joy when the stock goes down. That in itself shows an obvious agenda IMO.

Those that discuss the progress of the science, the trials, etc. are all still extremely positive based on the 100% successful trial results to date, the fact we are less than 200MM shares and have been able to advance three drugs to successful conclusion in P2 trials with no overhanging debt, and the obvious desire by BP to own our pipeline of products as evidenced by the numerous CDA's.

Volume is obviously being manipulated by MM's being the henchmen for those that need the price to stay low and their need for lots of shares which they have shorted, and have not been able to cover though they have been trying relentlessly for nearly a year, is going to come to bite them in the ass royally in the not too distant future.

I do hear some exasperation from true stockholders over the share price but to a man they realize it is a complete disconnect with the true value of the company. This is evidenced by Brilacidin already being a multi-billion dollar drug with its impressive results against UC, OM, ABSSSI, and Dr. B expressing such optimism for it as a major player of the future in the dermatology arena which it will target within a year or so. K is already a multi-billion dollar drug with its successful evidence of working in the p53 pathway as it showed in pre-clinical trials and met the goals of the OC trial which was set up by BP to answer their main questions as to how K worked in attacking tumors. It passed w/ flying colors.

Current speed bumps include finalizing the oral delivery method for both K and B, a gel/foam for B for use in sigmoid colitis of the anal region of the GI tract, and getting Compassionate Use OK for both B and K in addition to the obvious delay of the P top end results which are no fault of the company or mgt. These are just current delays, nothing out of the ordinary for bio yet made to look like the death of the company by those trying to scare shares out of longs hands.

There are obviously a boatload of eyes on this board by many who never speak up and share their thoughts, many who most likely have a nice position in the company, and some support from them would be most welcome but that cannot be counted on. I do believe the vast majority of them know what they own and are as confident as those few of us who post positively on a regular basis.
The web traffic is impressive. And I do get PM's here and there of posters that either only post on the big boards or don't post at all.
Once this is off the OTC, they'll be coming out of the woodworks.


To those that denigrate IPIX, name one other bio start up, or even any other BP, that has the current explosive pipeline as does IPIX which addresses many, many multi-billion dollar markets and still has many more not even realized yet (as we have been told is the case w/ B, can be the case w/ P for auto-immune diseases), and most likely will occur with K as THE combo drug of choice for nearly every current cancer treatment on the market.

Easy to see why those of us w/ positive attitudes sleep well at night. We don't need to employ MM games, as those trying to keep the SP low do, to try and make our case.

That's so true.

Look for facts, not opinions, and put those on ignore that only deal in negative opinions not backed up with facts and the board becomes again a source of good info and not the current denigration of the company. It is like when graffiti artists paint railroad cars and downtown buildings for their "art" and then move on to leave nothing but a sore spot in the neighborhood. That is how I treat the negative posts with no factual backup

Innovation Pharmaceuticals Inc (IPIX) Stock Research Links

IPIX Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Tachyus Partners with Anschutz for Enhanced Carbon Management

Updated Category News Views 169

Tachyus Partners with Anschutz Exploration Tachyus has announced an exciting collaboration with Anschutz Exploration to implement Aurion, its innovative platform designed for efficient greenhouse gas (GHG) emissions management. This contract marks a significant step for Anschutz, aiming to establish a comprehensive GHG baseline while effectively monitoring and forecasting...

Continue Reading
Cypress Creek Renewable's New Solar Initiative in Colorado

Updated Category News Views 270

Cypress Creek Renewables Expands Solar Capacity Cypress Creek Renewables, a leader in solar energy and storage project development, has recently achieved a significant milestone with the financial closure of its Sundance Solar and Energy Storage project. This hybrid solar initiative, located in Colorado, boasts a remarkable 75MWac solar capacity along with an impressive...

Continue Reading
Acrivon Therapeutics Unveils Key Data at Two Major Conferences

Updated Category News Views 32

Acrivon Therapeutics Showcases AP3 Platform at Leading Conferences Acrivon Therapeutics, Inc. is set to demonstrate its innovative AP3 platform at two prominent scientific conferences within the upcoming days. This promising platform plays a pivotal role in the streamlined drug discovery and clinical advancement, particularly for its leading candidates, ACR-368 and...

Continue Reading
Nokia Corporation Reports Strong Performance in Q3 2025

Updated Category News Views 410

Nokia Corporation's Q3 2025 Interim Report Overview Nokia Corporation delivered an impressive performance in its third-quarter report, demonstrating significant net sales growth and operational stability. This report highlights the notable achievements and strategic initiatives undertaken by Nokia, outlining its path towards sustaining growth amid a competitive landscape....

Continue Reading
Home Fire Sprinklers: Cost-Effective Safety Solutions

Updated Category News Views 134

How Home Fire Sprinklers Can Lower Construction Costs and Save Lives Home fire sprinklers play a vital role in improving safety and protecting lives in residential properties, while also significantly lowering construction expenses. These modern systems offer a range of benefits when incorporated into new building projects. Cost Savings with Fire Sprinklers By installing...

Continue Reading